Critical Limb Ischemia Cli clinical trials

Explore recruiting critical limb ischemia cli clinical trials.

Recruiting critical limb ischemia cli studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Critical Limb Ischemia Cli trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 1/2, Open label & double-blind randomized placebo-controlled study to assess the feasibility of BGC101 (EnEPC) in the treatment of peripheral arterial disease (PAD) with critical limb ischemia (CLI)

Belgium

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Critical Limb Ischemia Cli trials by city

Critical Limb Ischemia Cli in Toronto Critical Limb Ischemia Cli in Vancouver Critical Limb Ischemia Cli in Montreal Critical Limb Ischemia Cli in Calgary Critical Limb Ischemia Cli in Edmonton Critical Limb Ischemia Cli in Ottawa Critical Limb Ischemia Cli in Winnipeg Critical Limb Ischemia Cli in Quebec City Critical Limb Ischemia Cli in Hamilton Critical Limb Ischemia Cli in Kitchener Critical Limb Ischemia Cli in London Critical Limb Ischemia Cli in Halifax Critical Limb Ischemia Cli in New York Critical Limb Ischemia Cli in Los Angeles Critical Limb Ischemia Cli in Chicago Critical Limb Ischemia Cli in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease